Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-17 5:25 pm Sale | 2022-01-12 | 13D | Immunocore Holdings plc IMCR | GENERAL ATLANTIC L.P. | 3,225,700 7.100% | -614,969 (-16.01%) | Filing History |
| 2023-01-03 6:56 pm Sale | 2022-12-29 | 13D | Immunocore Holdings plc IMCR | GENERAL ATLANTIC L.P. | 3,840,669 8.480% | -516,223 (-11.85%) | Filing History |
| 2022-12-20 5:13 pm Sale | 2022-12-16 | 13D | Immunocore Holdings plc IMCR | GENERAL ATLANTIC L.P. | 4,356,892 9.620% | -965,683 (-18.14%) | Filing History |
| 2022-09-07 11:37 am Sale | 2022-08-31 | 13G | Immunocore Holdings plc IMCR | Malin Life Sciences Holdings Limited | 2,109,425 4.560% | -280,554 (-11.74%) | Filing History |
| 2022-07-21 5:13 pm Purchase | 2022-07-20 | 13D | Immunocore Holdings plc IMCR | GENERAL ATLANTIC L.P. | 5,322,575 11.500% | 5,322,575 (New Position) | Filing History |
| 2022-07-20 5:12 pm Purchase | 2022-07-15 | 13D | Immunocore Holdings plc IMCR | BAKER BROS. ADVISORS LP | 4,685,690 9.930% | 1,333,333 (+39.77%) | Filing History |
| 2022-03-17 08:19 am Purchase | 2022-03-01 | 13G | Immunocore Holdings plc IMCR | Cross Nicholas John | 2,369,610 5.400% | 2,369,610 (New Position) | Filing History |
| 2022-02-18 3:35 pm Purchase | 2021-12-31 | 13G | Immunocore Holdings plc IMCR | Laing Ian Michael | 2,358,650 5.400% | 2,358,650 (New Position) | Filing History |
| 2022-02-14 6:23 pm Purchase | 2021-12-31 | 13G | Immunocore Holdings plc IMCR | Rock Springs Capital Management LP | 2,471,555 5.640% | 141,770 (+6.09%) | Filing History |
| 2022-02-10 4:55 pm Purchase | 2021-12-31 | 13G | Immunocore Holdings plc IMCR | Malin Life Sciences Holdings Limited | 2,389,979 5.450% | 30,554 (+1.29%) | Filing History |
| 2022-02-10 4:05 pm Purchase | 2021-12-31 | 13G | Immunocore Holdings plc IMCR | ELI LILLY & Co LLY | 2,548,145 5.800% | 2,548,145 (New Position) | Filing History |
| 2021-10-15 1:17 pm Purchase | 2021-10-15 | 13G | Immunocore Holdings plc IMCR | Malin Life Sciences Holdings Limited | 2,359,425 5.390% | 2,359,425 (New Position) | Filing History |
| 2021-05-20 5:25 pm Unchanged | 2021-05-10 | 13D | Immunocore Holdings plc IMCR | BAKER BROS. ADVISORS LP | 3,352,357 7.700% | 0 (Unchanged) | Filing History |
| 2021-04-19 4:25 pm Purchase | 2021-04-09 | 13G | Immunocore Holdings plc IMCR | Rock Springs Capital Management LP | 2,329,785 5.320% | 2,329,785 (New Position) | Filing History |
| 2021-02-16 4:58 pm Purchase | 2021-02-16 | 13G | Immunocore Holdings plc IMCR | BAKER BROS. ADVISORS LP | 3,352,357 7.500% | 3,352,357 (New Position) | Filing History |